A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Interventions:   Drug: CCX168;   Drug: Midazolam;   Drug: Celecoxib;   Drug: Itraconazole;   Drug: Rifampicin Sponsor:   Amgen Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials